Search

everythinglearnresearchcommunity

for

Search:↓

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Minoxidil solution safely and effectively treats hair loss.

Sudden hair loss might be a symptom of COVID-19.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

A man had temporary hair loss after a spinal cord injury, with some permanent thinning remaining.

A man had nail and hair changes months after severe Covid-19, showing long-term effects.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Electrospun scaffolds can improve healing in diabetic wounds.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

A boy developed a rare skin condition after recovering from a severe skin reaction, and it improved with lotion treatment.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

EtG levels in hair decrease significantly after one month of alcohol abstinence.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.